ECO Animal Health Group (LON:EAH) Price Target Raised to GBX 160

ECO Animal Health Group (LON:EAH) had its price objective upped by Shore Capital from GBX 150 to GBX 160 in a report published on Tuesday, MarketBeat.com reports. They currently have a buy rating on the stock.

ECO Animal Health Group Price Performance

Shares of EAH stock opened at GBX 108.10 on Tuesday. ECO Animal Health Group has a 52-week low of GBX 50 and a 52-week high of GBX 114. The stock has a market cap of £72.96 million, a PE ratio of 44.49 and a beta of -0.05. The company has a debt-to-equity ratio of 4.81, a quick ratio of 2.14 and a current ratio of 2.96. The firm’s 50 day moving average price is GBX 89.52 and its two-hundred day moving average price is GBX 76.67.

ECO Animal Health Group (LON:EAH) last issued its earnings results on Monday, December 1st. The company reported GBX (0.54) EPS for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

Insiders Place Their Bets

In related news, insider David Hallas bought 18,348 shares of the business’s stock in a transaction on Thursday, December 4th. The shares were purchased at an average price of GBX 109 per share, with a total value of £19,999.32. Insiders own 11.03% of the company’s stock.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.